A CLINICAL STUDY ON THE MANAGEMENT OF AMLAPITTA WITH WITH NARIKELA LAVANA

Abstract

INTRODUCTION: The Amlapitta is constituted of the words Amla and Pitta. The term Amla has been used as an appellation to Pitta. Though, the Amla has been said as natural property of Pitta along with Katu Rasa, according to Charaka. Sushruta has enlisted as its original rasa and mentioned that when the Pitta becomes Vidagdha, it transforms to Amla in Rasa By considering the disease as well as its symptoms, it seems that in Amlapitta, the Pitta seems distorted or is Vidagdha, as mentioned by Acharya Sushruta. Shrikantadatta in this commentary here, has defined that Amlapitta is a condition where excessive secretion of pitta with Amla in Guna takes place resulting in the condition like Vidaha, Tikta-Amlodgara etc. The review of Vedic Literature points to no known suggestive references regarding the description of Amlapitta. Eventually Acharya Charaka has not mentioned Amlapitta as a separate entity in the Samhita, while describing Grahaniroga, pathogenesis of Amlapitta has been clearly mentioned, while explaining the role of Agnidushti and its role in the manifestation of diseases by affecting the three Doshas, mainly the pitta. Madhava Nidana is the first text which describes its aetio-pathogenesis & symptoms. It classified Amlapitta into two clinical subtypes(i) Urdhwaghataamlapitta (ii) Adhoghataamlapitta). It also explained Lakshanas like Avipaka, Klama, Utklesha, Amlodgara, Hrt-kantaDaha, &Aruchi etc. Dyspepsia is defined by the ROME III committee on functional gastro-intestinal disorders as chronic or recurrent pain or discomfort centered in the upper abdomen. Discomfort means different things to different people but typically encompasses symptoms such as Bloating, Abdominal fullness, Early satiety and Nausea. It is an extremely common disorder in other- wise healthy population. Majority of patients however will be classified as having Non -Ulcer or Functional Dyspepsia. Prevalence of Functional Dyspepsia is about 20-30 % worldwide. A study from India reported to be 30.4%. The treatment option of recent origin described in American Journal of Gastroenterology is (i) test and treat for H. pylori using a validated non- invasive test and a trial of acid suppression. (ii) an empirical trial of acid suppression with a proton -pump inhibhitor is an initial option in a low prevalence area. Narikelalavanamentioned in Rasatarangini, indicated in Amlapitta. It is Laghu, Snighda, Sheetavirya, & Madhura vipaka. The present study aims to evaluate the general potential of oral administration of NarikelaLavanato prevent the progression of the disease and to relieve the symptoms. AIM: To carry out a Clinical Study on the Management of Amlapitta with NarikelaLavana. OBJECTIVES: Assessment of the clinical utility of Narikelalavana in Amlapitta as assessed by; Classical symptoms, GSRS Scale (Gastro-intestinal Symptom Rating scale) and QOLRAD Scale (Quality of Life in Reflux and Dyspepsia). METHODOLOGY: study design: open labelled clinical trial study selection: Patients suffering from amlapitta aged btween 20-50 years of either gender were taken in the study with chronicity of symptoms less than one month was selected from Parulayurved hospital, Vadodara. intervention: Patients treated with narikelalavana 1gms thrice daily before food with go ghrta for 14 days. RESULTS: The results were analysed before and after treatment based on assessment parameters, such as classical symptoms, GSRS Scale and QolRAD questionnaire using onw-way anova test. CONCLUSION: This study confirms that Narikelalavana is effective in Amlapitta.